Showing results (201-210 of 220) with videos related to
Sort By:
Pageof 22
The American Journal of Gastroenterology|April 13, 2022
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness PanelParambir S Dulai, Victoria Rai, Laura E Raffals, et al.Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]Simon P L Travis, Dan Schnell, Brian G Feagan, et al.Inflammatory Bowel Diseases|April 29, 2025
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC StudiesStefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, et al.Gastroenterology|July 30, 2013
Reliability and initial validation of the ulcerative colitis endoscopic index of severitySimon P L Travis, Dan Schnell, Piotr Krzeski, et al.Gut|October 15, 2011
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Simon P L Travis, Dan Schnell, Piotr Krzeski, et al.Journal of Crohn'S & Colitis|December 19, 2013
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational studyPeter R Gibson, Carolynne Vaizey, Christopher M Black, et al.Inflammatory Bowel Diseases|February 8, 2013
Quality indicators for inflammatory bowel disease: development of process and outcome measuresGil Y Melmed, Corey Allan Siegel, Brennan M Spiegel, et al.BMC Medical Genetics|August 31, 2017
Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score methodGuo-Bo Chen, Sang Hong Lee, Grant W Montgomery, et al.Gastroenterology|February 5, 2022
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial ResultsGeert R D'Haens, William J Sandborn, Edward V Loftus, et al.The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.Pageof 22